Moreover, PSEN1 does not possess a single nonsense mutation, meaning that all known PSEN1 mutations or SNPs likely alter PSEN1 function and in this way contribute to AD pathology and the patient's response to PSEN1‐targeted therapeutics. The gene discussed is PSEN1; the disease is Alzheimer disease.